David Lechuga-Ballesteros

This inventor holds 22 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Nektar Therapeutics, Pearl Therapeutics, Inc., Abbott Laboratories Corporation. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Lechuga-Ballesteros. Retrieved from https://idiyas.com/inventor/david-lechuga-ballesteros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 15)

% Patents Active = 72.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 9

Forward Citations = 357(Granted Patents)

Location History:

Santa Clara, CA (US) (2002 - 2014)
San Jose, CA (US) (2008 - 2022)

Company Filing History:

Pearl Therapeutics, Inc.

patents

3 out of 4,190

Abbott Laboratories Corporation

patents

4. 3 out of 9

Aridis Pharmaceuticals

patents

5. 2 out of 60

Inhale Therapeutic Systems, Inc.

Years Active: 2002-2022

Loading Chart...

Areas of Expertise:

Particulate Crystalline Materials

Respiratory Delivery

Gallium Formulation

Pharmaceutical Composition

Water-Insoluble Agent

Dry Powder Compositions

Active Agents

Amphotericin B

Liquid Crystal Forms

Infectious Diseases

Crystalline Pharmaceutical

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11471468 - Methods and systems for conditioning of particulate crystalline materials (2022-10-18),

2. 11129794 - Chemically modified small molecules (2021-09-28),

3. 9539233 - Gallium formulation for the treatment and prevention of infectious diseases (2017-01-10),

4. 9415009 - Compositions, methods and systems for respiratory delivery of two or more active agents (2016-08-16),

5. 8815258 - Compositions, methods and systems for respiratory delivery of two or more active agents (2014-08-26),

6. 8796451 - Crystalline pharmaceutical (2014-08-05),

7. 8703806 - Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents (2014-04-22),

8. 8668934 - Pharmaceutical formulation comprising a water-insoluble active agent (2014-03-11),

9. 8637090 - Gallium formulation for the treatment and prevention of infectious diseases (2014-01-28),

10. 8501240 - Compositions comprising an active agent (2013-08-06),

11. 8324266 - Compositions, methods and systems for respiratory delivery of two or more active agents (2012-12-04),

12. 8241886 - Formulations for preservation of rotavirus (2012-08-14),

13. 8067431 - Chemically modified small molecules (2011-11-29),

14. 8058433 - Crystalline pharmaceutical (2011-11-15),

15. 7862834 - Pharmaceutical formulation comprising a water-insoluble active agent (2011-01-04),

Title: The Innovative Journey of David Lechuga-Ballesteros

Introduction: David Lechuga-Ballesteros is a visionary inventor based in San Jose, CA, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: David Lechuga-Ballesteros holds several patents in various industries, including cutting-edge advancements in artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, David has worked with renowned tech companies, leading research institutions, and universities to bring his innovative ideas to life. His dedication to pushing the boundaries of technology has earned him recognition as a pioneer in his field.

Collaborations: Throughout his career, David has collaborated with top engineers, scientists, and researchers to develop revolutionary solutions to complex challenges. His ability to work across disciplines has led to the creation of groundbreaking technologies that have the potential to shape the future.

Conclusion: David Lechuga-Ballesteros continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of excellence in all his endeavors. His impact on the world of technology is truly remarkable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.